BeOne Medicines Ltd. Sponsored ADRBeOne Medicines Ltd. Sponsored ADRBeOne Medicines Ltd. Sponsored ADR

BeOne Medicines Ltd. Sponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪43.49 B‬USD
−1.68USD
‪−645.11 M‬USD
‪3.81 B‬USD
‪100.21 M‬
Beta (1Y)
0.64

About BeOne Medicines Ltd. Class A


CEO
John V. Oyler
Headquarters
Basel
Founded
2010
ISIN
US07725L1026
FIGI
BBG00B6WF7T5
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as ONC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
IBB
iShares Biotechnology ETF
Weight
2.06%
Market value
‪127.13 M‬
USD
FBT
First Trust NYSE Arca Biotechnology Index Fund
Weight
4.11%
Market value
‪46.96 M‬
USD
BBH
VanEck Biotech ETF
Weight
4.54%
Market value
‪15.86 M‬
USD
2820
Global X China Biotech ETF
Weight
9.67%
Market value
‪8.95 M‬
USD
CGGE
Capital Group Global Equity ETF
Weight
0.75%
Market value
‪8.18 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.02%
Market value
‪6.43 M‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.02%
Market value
‪6.43 M‬
USD
371470
MIRAE ASSET TIGER CHINA BIOTECH SOLACTIVE ETF
Weight
8.35%
Market value
‪5.26 M‬
USD
SBIO
Invesco NASDAQ Biotech UCITS ETF
Weight
1.04%
Market value
‪3.80 M‬
USD
AVEM
Avantis Emerging Markets Equity ETF
Weight
0.03%
Market value
‪3.78 M‬
USD
ONEQ
Fidelity Nasdaq Composite Index ETF
Weight
0.03%
Market value
‪2.99 M‬
USD

Explore more ETFs